Gene · 4060
Papers3,622
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,622
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FN1 and TGFBI are key biomarkers of macrophage immune injury in diabetic kidney disease. | Medicine (Baltimore) | 2023 | 37960829 | PubTator, text mining | PubMed |
| MicroRNA and Protein Cargos of Human Limbal Epithelial Cell-Derived Exosomes and Their Regulatory Roles in Limbal Stromal Cells of Diabetic and Non-Diabetic Corneas. | Cells | 2023 | 37947602 | PubTator, text mining | PubMed |
| Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients. | Cells | 2023 | 37947594 | PubTator, text mining | PubMed |
| Functionally similar genes exhibit comparable/similar time-course expression kinetics in the UV-induced photoaged mouse model. | PLoS One | 2023 | 37943888 | PubTator, text mining | PubMed |
| Single-cell genomics reveals region-specific developmental trajectories underlying neuronal diversity in the human hypothalamus. | Sci Adv | 2023 | 37939194 | PubTator, text mining | PubMed |
| Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma. | Aging (Albany NY) | 2023 | 37934565 | PubTator, text mining | PubMed |
| Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system. | Biomater Res | 2023 | 37932837 | PubTator, text mining | PubMed |
| 3D bioprinted breast tumor-stroma models for pre-clinical drug testing. | Mater Today Bio | 2023 | 37928251 | PubTator, text mining | PubMed |
| Pathogenic mechanisms and therapeutic implications of extracellular matrix remodelling in cerebral vasospasm. | Fluids Barriers CNS | 2023 | 37925414 | PubTator, text mining | PubMed |
| Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. | EBioMedicine | 2023 | 37924708 | PubTator, text mining | PubMed |
| Human dermal fibroblast subpopulations and epithelial mesenchymal transition signals in hidradenitis suppurativa tunnels are normalized by spleen tyrosine kinase antagonism in vivo. | PLoS One | 2023 | 37922232 | PubTator, text mining | PubMed |
| Characterization of the Limbal Epithelial Stem Cell Niche. | Invest Ophthalmol Vis Sci | 2023 | 37906057 | PubTator, text mining | PubMed |
| Achieving quantitative reproducibility in label-free multisite DIA experiments through multirun alignment. | Commun Biol | 2023 | 37903988 | PubTator, text mining | PubMed |
| Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice. | Front Immunol | 2023 | 37901252 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 24 Spanish Families: Candidate Genes for Non-Syndromic Pediatric Keratoconus. | Genes (Basel) | 2023 | 37895187 | PubTator, text mining | PubMed |
| Effect of Aging on Tendon Biology, Biomechanics and Implications for Treatment Approaches. | Int J Mol Sci | 2023 | 37894875 | PubTator, text mining | PubMed |
| Synthesis and Characterization of a Biopolymer Pectin/Ethanolic Extract from Olive Mill Wastewater: In Vitro Safety and Efficacy Tests on Skin Wound Healing. | Int J Mol Sci | 2023 | 37894755 | PubTator, text mining | PubMed |
| Mucin Glycans: A Target for Cancer Therapy. | Molecules | 2023 | 37894512 | PubTator, text mining | PubMed |
| Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2023 | 37894284 | PubTator, text mining | PubMed |
| Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression. | Cancer Cell | 2023 | 37890493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4060/papers?page=17